Hangzhou Qiwei Pharmatech Co.,Ltd was founded in 2016. We focus on providing small molecule, new modalities and CDMO services for global pharmaceutical and biotech industry. We are committed to building a high-quality CRO&CDMO platform in research, development, manufacturing, and supplying of reference compounds, novel building blocks, intermediates, APIs and drug products. Over the past few years, we have established a state-of-the-art QC/QA system aligning with ICH guidelines for pharmaceutical manufacturing. We provide our clients with high-quality products and CMC services across the entire life-cycle of drug development.